share_log

天茂集团:天茂集团第九届董事会提名委员会关于董事候选人任职资格的审查意见

Hubei Biocause Pharmaceutical: The board of directors nomination committee of Hubei Biocause Pharmaceutical's 9th session has reviewed the qualifications of director candidates.

SZSI ·  Aug 13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more